Skip to main content

2017 | OriginalPaper | Buchkapitel

10. Cost Effectiveness Analysis

verfasst von : Jean-Michel Josselin, Benoît Le Maux

Erschienen in: Statistical Tools for Program Evaluation

Verlag: Springer International Publishing

Aktivieren Sie unsere intelligente Suche um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Cost effectiveness analysis compares the differential costs and outcomes of policy strategies competing for the implementation of a program. Outcomes are measured by arithmetical or physical units instead of by an equivalent money value (Sect. 10.1). Indicators of cost effectiveness are the incremental cost effectiveness ratio and its generalization as a function of collective willingness to pay, i.e. the incremental net benefit (Sect. 10.2). Beyond the pairwise comparison of strategies through those indicators, the efficiency frontier identifies policy options subject to simple and extended dominance, and selects the efficient ones (Sect. 10.3). Cost and outcome data is usually obtained from decision analytic modeling, here Markov models (Sect. 10.4). Section 10.5 provides a numerical example in R-CRAN. Cost effectiveness analysis is notably used in public health economics where the health outcome of a medical intervention is assessed by quality-adjusted life years (Sect. 10.6). Section 10.7 debates the uncertainty surrounding decision analytic models and uses Monte Carlo simulations to address parameter uncertainty. Section 10.8 shows how to analyze simulation outputs on the differential cost-effectiveness plane and with cost effectiveness acceptability curves, with self-contained R-CRAN programs.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literatur
Zurück zum Zitat Barton, G., Briggs, A., & Fenwick, E. (2008). Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value in Health, 11, 886–897.CrossRef Barton, G., Briggs, A., & Fenwick, E. (2008). Optimal cost-effectiveness decisions: The role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI). Value in Health, 11, 886–897.CrossRef
Zurück zum Zitat Black, W. (1990). The CE plane: A graphic representation of cost-effectiveness. Medical Decision Making, 10, 212–214.CrossRef Black, W. (1990). The CE plane: A graphic representation of cost-effectiveness. Medical Decision Making, 10, 212–214.CrossRef
Zurück zum Zitat Brennan, A., Chick, S., & Davies, R. (2006). A taxonomy of model structures for economic evaluation of health technologies. Health Economics, 15, 1295–1310.CrossRef Brennan, A., Chick, S., & Davies, R. (2006). A taxonomy of model structures for economic evaluation of health technologies. Health Economics, 15, 1295–1310.CrossRef
Zurück zum Zitat Briggs, A., & Sculpher, M. (1998). An introduction to Markov modelling for economic evaluation. PharmacoEconomics, 13, 397–409.CrossRef Briggs, A., & Sculpher, M. (1998). An introduction to Markov modelling for economic evaluation. PharmacoEconomics, 13, 397–409.CrossRef
Zurück zum Zitat Briggs, A., Claxton, K., & Sculpher, M. (2006). Decision modelling for health economic evaluation. Oxford: Oxford University Press. Briggs, A., Claxton, K., & Sculpher, M. (2006). Decision modelling for health economic evaluation. Oxford: Oxford University Press.
Zurück zum Zitat Briggs, A., Weinstein, M., Fenwick, E., Karnon, J., Sculpher, M., & Paltiel, A. (2012). Model parameter estimation and uncertainty: A report of the ISPOR-SMDM modelling good research practices task force-6. Value in Health, 15, 835–842.CrossRef Briggs, A., Weinstein, M., Fenwick, E., Karnon, J., Sculpher, M., & Paltiel, A. (2012). Model parameter estimation and uncertainty: A report of the ISPOR-SMDM modelling good research practices task force-6. Value in Health, 15, 835–842.CrossRef
Zurück zum Zitat Claxton, K. (2008). Exploring uncertainty in cost-effectiveness analysis. PharmacoEconomics, 26, 781–798.CrossRef Claxton, K. (2008). Exploring uncertainty in cost-effectiveness analysis. PharmacoEconomics, 26, 781–798.CrossRef
Zurück zum Zitat Drummond, M., & McGuire, A. (Eds.). (2001). Economic evaluation in health care programs: Merging theory with practice. Oxford: Oxford University Press. Drummond, M., & McGuire, A. (Eds.). (2001). Economic evaluation in health care programs: Merging theory with practice. Oxford: Oxford University Press.
Zurück zum Zitat Drummond, M., Stoddart, G., & Torrance, G. (1987). Methods for the economic evaluation of health care programs. Oxford: Oxford University Press. Drummond, M., Stoddart, G., & Torrance, G. (1987). Methods for the economic evaluation of health care programs. Oxford: Oxford University Press.
Zurück zum Zitat Drummond, M., Sculpher, M., Claxton, K., Stoddart, G., & Torrance, G. (2015). Methods for the economic evaluation of health care programs. Oxford: Oxford University Press. Drummond, M., Sculpher, M., Claxton, K., Stoddart, G., & Torrance, G. (2015). Methods for the economic evaluation of health care programs. Oxford: Oxford University Press.
Zurück zum Zitat Edlin, R., McCabe, C., Hulme, C., Hall, P., & Wright, J. (2015). Cost effectiveness modelling for health technology assessment. Heidelberg: Springer.CrossRef Edlin, R., McCabe, C., Hulme, C., Hall, P., & Wright, J. (2015). Cost effectiveness modelling for health technology assessment. Heidelberg: Springer.CrossRef
Zurück zum Zitat Ghabri, S., Hamers, F., & Josselin, J.-M. (2016). Exploring uncertainty in economic evaluations of new drugs and medical devices: Lessons from the first review of manufacturers’ submissions to the French National Authority for Health. PharmacoEconomics, 34, 617–624. Ghabri, S., Hamers, F., & Josselin, J.-M. (2016). Exploring uncertainty in economic evaluations of new drugs and medical devices: Lessons from the first review of manufacturers’ submissions to the French National Authority for Health. PharmacoEconomics, 34, 617–624.
Zurück zum Zitat Gold, M., Siegel, J., Russell, L., & Weinstein, M. (Eds.). (1996). Cost-effectiveness in health and medicine. Oxford: Oxford University Press. Gold, M., Siegel, J., Russell, L., & Weinstein, M. (Eds.). (1996). Cost-effectiveness in health and medicine. Oxford: Oxford University Press.
Zurück zum Zitat Heintz, E., Gerber-Grote, A., Ghabri, S., Hamers, F., Prevolnik Rupel, V., Slabe-Erker, R., et al. (2016). Is there a European view on health economic evaluation? Results from a synopsis of methodological guidelines used in the EUnetHTA partner countries. PharmacoEconomics, 34, 59–76.CrossRef Heintz, E., Gerber-Grote, A., Ghabri, S., Hamers, F., Prevolnik Rupel, V., Slabe-Erker, R., et al. (2016). Is there a European view on health economic evaluation? Results from a synopsis of methodological guidelines used in the EUnetHTA partner countries. PharmacoEconomics, 34, 59–76.CrossRef
Zurück zum Zitat Johannesson, M., & Weinstein, M. (1993). On the decision rules of cost-effectiveness analysis. Journal of Health Economics, 12, 459–467.CrossRef Johannesson, M., & Weinstein, M. (1993). On the decision rules of cost-effectiveness analysis. Journal of Health Economics, 12, 459–467.CrossRef
Zurück zum Zitat Kok, R., Annema, J., & van Wee, B. (2011). Cost-effectiveness of greenhouse gas mitigation in transport: A review of methodological approaches and their impact. Energy Policy, 39, 7776–7793.CrossRef Kok, R., Annema, J., & van Wee, B. (2011). Cost-effectiveness of greenhouse gas mitigation in transport: A review of methodological approaches and their impact. Energy Policy, 39, 7776–7793.CrossRef
Zurück zum Zitat Laska, E., Meisner, M., Siegel, C., & Wanderling, J. (2002). Statistical determination of cost-effectiveness frontier based on net health benefits. Health Economics, 11, 249–264.CrossRef Laska, E., Meisner, M., Siegel, C., & Wanderling, J. (2002). Statistical determination of cost-effectiveness frontier based on net health benefits. Health Economics, 11, 249–264.CrossRef
Zurück zum Zitat Levin, H., & McEwan, P. (2000). Cost-effectiveness analysis: Methods and applications. New York: Sage. Levin, H., & McEwan, P. (2000). Cost-effectiveness analysis: Methods and applications. New York: Sage.
Zurück zum Zitat Raimond, V., Josselin, J.-M., & Rochaix, L. (2014). HTA agencies facing model biases: The case of type-2 diabetes. PharmacoEconomics, 32, 825–839.CrossRef Raimond, V., Josselin, J.-M., & Rochaix, L. (2014). HTA agencies facing model biases: The case of type-2 diabetes. PharmacoEconomics, 32, 825–839.CrossRef
Zurück zum Zitat Shoup, D. (1973). Cost effectiveness of urban traffic law enforcement. Journal of Transport Economics and Policy, 7, 32–57. Shoup, D. (1973). Cost effectiveness of urban traffic law enforcement. Journal of Transport Economics and Policy, 7, 32–57.
Zurück zum Zitat Sonnenberg, F., & Beck, J. (1993). Markov models in medical decision making: A practical guide. Medical Decision Making, 13, 322–339.CrossRef Sonnenberg, F., & Beck, J. (1993). Markov models in medical decision making: A practical guide. Medical Decision Making, 13, 322–339.CrossRef
Zurück zum Zitat Stinnett, A., & Mullahy, J. (1998). Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making, 18, S68–S80.CrossRef Stinnett, A., & Mullahy, J. (1998). Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making, 18, S68–S80.CrossRef
Zurück zum Zitat Willan, A. (2011). Sample size determination for cost effectiveness trials. PharmacoEconomics, 29, 933–949.CrossRef Willan, A. (2011). Sample size determination for cost effectiveness trials. PharmacoEconomics, 29, 933–949.CrossRef
Metadaten
Titel
Cost Effectiveness Analysis
verfasst von
Jean-Michel Josselin
Benoît Le Maux
Copyright-Jahr
2017
DOI
https://doi.org/10.1007/978-3-319-52827-4_10